Hemp, Inc. HEMP
Because of the absolute bloodbath having been experienced by the market of late, it is easy to forget the huge development for those with vested interests in hemp, the male form of the cannabis plant. Of course, one of its biggest proponents for quite some time has been the aptly named, Hemp, Inc.
The recent passing of the farm bill that effectively green-lighted the hemp industry nationwide is a game changer, and it certainly showed up on the chart, which experienced a heck of a spike. Following our alert on HEMP from just a few weeks ago, the stock ran from .0292 up as high as .054, a move of 85%
There has been some pullback since then, but in general HEMP is a stock that we’re going to be very interested in tracking into the New Year. There is a golden cross setup in the works for the chart, so we could be looking at the next leg-up sooner rather than later.
The company has talked a big talk when it comes to federal legalization, and now that it has become a reality, we expect to see solid efforts from HEMP in 2019, starting with the cleaning up of its reporting status on OTC Markets.
ASNS, IMMU, MB,
Signet Jewelers Ltd. SIG – Options Idea
After noticing its solid beat on earnings and reassured guidance yesterday morning in the premarket, we selected a range of options ideas for the SIG chain. Post-earnings options calls have become our bread and butter, and SIG provided yet another example of the reason for that.
Our designated observation range was the SIG Weekly $47.50-50 Calls and all but the 49.50’s enjoyed considerable single-session gains for the day.
$47.50 Calls – Range: 3.70-6.30 – Max Gain: 70%
$48 Calls – Range: 3.21-7.12 – Max Gain: 122%
$48.50 Calls – Range: 3.10-6.00 – Max Gain: 94%
$49 Calls – Range: 2.72-6.17 – Max Gain: 127%
$50 Calls – Range: 1.97-5.21 – Max Gain: 164%
Fresh Options Idea:
Five Below, Inc. FIVE Weekly $90-95 Calls
Axovant Sciences, Inc. AXON
We also included a tag of AXON in yesterday morning’s report, and were met with a pretty good chance for a daily profit there as well. We noticed a slew of Form-4 buys come in on Tuesday, and lo and behold, yesterday the company released news of an $840M+ licensing deal for its Parkinson’s gene therapy.
From a morning low of 3.27, the stock reached a high of 4.64, representing a modest, but very respectable 42% move on the day. We’ll be sure to leave it on our radar in the event that a more sustained move is in the cards.
ONTX, MRTX, ZS, IMMU, CLWT, CLSD, CLRB
Petroleo Brasiliero SA (Petrobras) PBR
As we kick off a fresh trading week, we’re drawn to a familiar stock from the past in PBR. Our relationship in following and making successful calls with this play stretches back for years,
Recently, the stock had been falling on the heels of a solid run last month, and that decline was kicked into a higher gear last week as the company’s CEO resigned amid questions about the Brazilian economy. The turmoil has brought PBR to its lowest levels and most oversold point since December, as you can see on the chart below.
You can also see that those conditions led to a month-long run of considerable proportions, so we’re going to want to signal some longer-term options in case the pattern were to repeat itself. We’ll place the PBR 06/29 $11-12 Calls on watch in the days and weeks ahead.
The TJX Companies, Inc. TJX – Recap
We presented some longer term options ideas in our report from May 22nd as well, and wanted to update our readers on the fantastic gains that have been made possible by the stock’s continuous bull run since that time.
Our targets were the TJX 06/15 $85-90 Calls, and the excellent moves made by those contracts are as follows:
$85 Calls – Range: 2.14-6.30 – Max Gain: 194%
$87.50 Calls – Range: .90-3.80 – Max Gain: 322%
$90 Calls – Range: .35-2.00 – Max Gain: 471%
ATIS, AXON, MUSZ, ENT, EOLS, MRNS, IMMU